Longitudinal Adherence to Fecal Occult Blood Testing Impacts Colorectal Cancer Screening Quality

[1]  J. Windsor,et al.  Infected pancreatic necrosis: not necessarily a late event in acute pancreatitis. , 2011, World journal of gastroenterology.

[2]  Katrina M. Krause,et al.  Obesity and Receipt of Clinical Preventive Services in Veterans , 2010, Obesity.

[3]  J. Windsor,et al.  Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. , 2010, Gastroenterology.

[4]  Dawn Provenzale,et al.  Colorectal cancer: national and international perspective on the burden of disease and public health impact. , 2010, Gastroenterology.

[5]  C. Klabunde,et al.  Trends in colorectal cancer test use in the medicare population, 1998-2005. , 2009, American journal of preventive medicine.

[6]  O. Dominic,et al.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009, The American Journal of Gastroenterology.

[7]  S. Chari,et al.  T1302 Moderately Severe Acute Pancreatitis: A Prospective Validation Study of This New Subgroup of Acute Pancreatitis , 2009 .

[8]  Douglas K Rex,et al.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2022 .

[9]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[10]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[11]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[12]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[13]  J. Ross,et al.  Use of preventive care by elderly male veterans receiving care through the Veterans Health Administration, Medicare fee-for-service, and Medicare HMO plans. , 2007, American journal of public health.

[14]  N. Shaheen,et al.  Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  M. Valenstein,et al.  Effect of a medication copayment increase in veterans with schizophrenia. , 2007, The American journal of managed care.

[16]  G. Cooper,et al.  The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. , 2006, Archives of internal medicine.

[17]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[18]  C. Johnson,et al.  Painful ascites , 2004, Gut.

[19]  G. Cooper,et al.  Geographic Variation among Medicare Beneficiaries in the Use of Colorectal Carcinoma Screening Procedures , 2004, American Journal of Gastroenterology.

[20]  L. Walter,et al.  Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. , 2004, JAMA.

[21]  Michelle L. Klosterman,et al.  Adherence with colorectal cancer screening guidelines: a review. , 2004, Preventive medicine.

[22]  Jing-xia Zhang,et al.  Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in China. , 2004, World journal of gastroenterology.

[23]  J. Avorn,et al.  Improved comorbidity adjustment for predicting mortality in Medicare populations. , 2003, Health services research.

[24]  Christopher B. Forrest,et al.  Adherence of low-income women to cancer screening recommendations , 2002, Journal of general internal medicine.

[25]  B. Rau,et al.  Early Severe Acute Pancreatitis: Characteristics of a New Subgroup , 2001, Pancreas.

[26]  A. Sonnenberg,et al.  Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer , 2000, Annals of Internal Medicine.

[27]  D. Cowper,et al.  Dual use of VA and non-VA primary care , 1999, Journal of general internal medicine.

[28]  K W Kizer,et al.  Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. , 1999, The New England journal of medicine.

[29]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[30]  W Thomas,et al.  Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1995, American journal of epidemiology.

[31]  R. Myers,et al.  Adherence to Continuous Screening for Colorectal Neoplasia , 1993, Medical care.

[32]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[33]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[34]  Minhua Chen.  Classifi cation of the Severity of Acute Pancreatitis , 2011 .

[35]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[36]  J. Windsor,et al.  Classification of the Severity of Acute Pancreatitis: How Many Categories Make Sense? , 2010, The American Journal of Gastroenterology.

[37]  S. Vickers.  Characterization of Newer Subgroups of Fulminant and Subfulminant Pancreatitis Associated With a High Early Mortality , 2009 .

[38]  Use of colorectal cancer tests--United States, 2002, 2004, and 2006. , 2008, MMWR. Morbidity and mortality weekly report.

[39]  Mph Dr. Steven J. Borowsky MD,et al.  Dual use of VA and non-VA primary care , 2007, Journal of General Internal Medicine.